Dopamine receptor contribution to the action of PCP, LSD and ketamine psychotomimetics
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Although phencyclidine and ketamine are used to model a hypoglutamate theory of schizophrenia, their selectivity for NMDA receptors has been questioned. To determine the affinities of phencyclidine, ketamine, dizocilpine and LSD for the functional high-affinity state of the dopamine D2 receptor, D2High, their dissociation constants (Ki) were obtained on [3H]domperidone binding to human cloned dopamine D2 receptors. Phencyclidine had a high affinity for D2High with a Ki of 2.7 nM, in contrast to its low affinity for the NMDA receptor, with a Ki of 313 nM, as labeled by [3H]dizocilpine on rat striatal tissue. Ketamine also had a high affinity for D2High with a Ki of 55 nM, an affinity higher than its 3100 nM Ki for the NMDA sites. Dizocilpine had a Ki of 0.3 nM at D2High, but a Kd of 1.8 nM at the NMDA receptor. LSD had a Ki of 2 nM at D2High. Because the psychotomimetics had higher potency at D2High than at the NMDA site, the psychotomimetic action of these drugs must have a major contribution from D2 agonism. Because these drugs have a combined action on both dopamine receptors and NMDA receptors, these drugs, when given in vivo, test a combined hyperdopamine and hypoglutamate theory of psychosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“a set of studies observed a high affinity of ketamine for the human D2 receptor expressed in Chinese Hamster Ovary cells (0.5 μM, Ki = 55 μM) and rat striatal 5-HT2 receptor (15 μM) (Kapur & Seeman, 2002; Seeman et al., 2005).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Seeman et al., 2005
Citations
Cites
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Jentsch, J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,314
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia
Goff, D. C., & Coyle, J. T. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.9.1367 · Cited by 915
Atypical antipsychotics: Mechanism of action
Seeman, P. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700106 · Cited by 899
Self-citationDopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880
Self-citationLee, F. J. S., Xue, S., Pei, L., Vukusic, B., Chéry, N., Wang, Y., Wang, Y. T., Niznik, H. B., Yu, X.-M., & Liu, F. (2002) · Cell · doi:10.1016/s0092-8674(02)00962-5 · Cited by 542
Köhler, C., Hall, H., Ögren, S.-O., & Gawell, L. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90778-6 · Cited by 505
Kapur, S., & Seeman, P. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001093 · Cited by 459
Self-citationInteractive effects of subanesthetic ketamine and haloperidol in healthy humans
Krystal, J. H., D'Souza, D. C., Karper, L. P., Bennett, A., Abi-Dargham, A., Abi-Saab, D., Cassello, K., Bowers Jr., M. B., Vegso, S., Heninger, G. R., et al. (1999) · Psychopharmacology · doi:10.1007/s002130051049 · Cited by 243
Regulation of Dopamine D1 Receptor Function by Physical Interaction with the NMDA Receptors
Pei, L., Lee, F. J. S., Moszczynska, A., Vukusic, B., & Liu, F. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3922-03.2004 · Cited by 209
Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
Seeman, P., Niznik, H. B., Guan, H. C., Booth, G., & Ulpian, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.24.10156 · Cited by 191
Self-citationTricyclic antidepressants block N‐methyl‐D‐aspartate receptors: similarities to the action of zinc
Reynolds, I. J., & Miller, R. J. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb16552.x · Cited by 191
GEORGE, S. R., WATANABE, M., PAOLO, T. D., FALARDEAU, P., LABRIE, F., & SEEMAN, P. (1985) · Endocrinology · doi:10.1210/endo-117-2-690 · Cited by 171
Self-citationSeeman, P., Ulpian, C., Wreggett, K. A., & Wells, J. W. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb06700.x · Cited by 169
Self-citationGrigoriadis, D. E., & Seeman, P. M. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07189.x · Cited by 142
Self-citationDopamine D2 receptor binding sites for agonists. A tetrahedral model.
Seeman, P., Watanabe, M., Grigoriadis, D., Tedesco, J. L., George, S. R., Svensson, U., Nilsson, J. L., & Neumeyer, J. L. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14176-x · Cited by 135
Self-citationSeeman, P., Tallerico, T., & Ko, F. (2003) · Synapse · doi:10.1002/syn.10232 · Cited by 128
Self-citationPhencyclidine- and Dizocilpine-Induced Hyperlocomotion Are Differentially Mediated
Ögren, S. O., & Goldstein, M. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380103 · Cited by 114
Effects of Remoxipride and some Related New Substituted Salicylamides on Rat Brain Receptors
Hall*, H., Sällemark, M., & Jerning, E. (1986) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1986.tb00071.x · Cited by 101
Glutamate pharmacology and the treatment of schizophrenia: current status and future directions
Tamminga, C. A., Holcomb, H. H., Gao, X. M., & Lahti, A. C. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199509000-00005 · Cited by 74
Direct stimulation of pituitary prolactin release by glutamate
Login, I. S. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90158-n · Cited by 60
Giacomelli, S., Palmery, M., Romanelli, L., Cheng, C. Y., & Silvestrini, B. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00262-8 · Cited by 57
Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro
Murray, F., Kennedy, J. D., Hutson, P. H., Elliot, J., Huscroft, I. T., Mohnen, K., Russell, M. G. N., & Grimwood, S. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00263-6 · Cited by 56
Acute Ketamine Intoxication Treated by Haloperidol: A Preliminary Study
Giannini, A. J., Underwood, N. A., & Condon, M. (2000) · American Journal of Therapeutics · doi:10.1097/00045391-200007060-00008 · Cited by 53
Comparison of Haloperidol and Chlorpromazine in the Treatment of Phencyclidine Psychosis
Giannini, A. J., EIGHAN, M. S., Loiselle, R. H., & Giannini, M. C. (1984) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1984.tb01831.x · Cited by 51
Grimwood, S., Bourdellès, B. L., Atack, J. R., Barton, C. L., Cockett, W., Cook, S. M., Gilbert, E., Hutson, P. H., McKernan, R. M., Myers, J., et al. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66062239.x · Cited by 51
Pampillo, M., Theas, M. S., Duvilanski, B., Seilicovich, A., & Lasaga, M. (2002) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2002-29092 · Cited by 41
The human dopamine D2Longer receptor has a high-affinity state and inhibits adenylyl cyclase
Liu, I. S. C., George, S. R., & Seeman, P. M. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00064-4 · Cited by 36
Self-citationGiannini, A. J., Nageotte, C., Loiselle, R. H., Malone, D. A., & Price, W. A. (1984) · Journal of Toxicology: Clinical Toxicology · doi:10.3109/15563658408992586 · Cited by 36
D1 and NMDA receptors hook up: expanding on an emerging theme
Salter, M. W. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00081-x · Cited by 35
Lysergic acid diethylamide: Evidence for stimulation of pituitary dopamine receptors
Meltzer, H. Y., Fessler, R. G., Simonovic, M., Doherty, J. D., & Fang, V. S. (1977) · Psychopharmacology · doi:10.1007/bf00426539 · Cited by 25
Seeman, P. M., Sunahara, R. K., & Niznik, H. B. (1994) · Synapse · doi:10.1002/syn.890170107 · Cited by 24
Self-citationEffects of phencyclidine on rat prolactin dopamine receptor and locomotor activity
Lozovsky, D. B., Saller, C. F., Bayorh, M. A., Chiueh, C. C., Rice, K. C., Burke, T. R., & Kopin, I. J. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90392-2 · Cited by 23
Link between dopamine D1 and D2 receptors in rat and human striatal tissues
Seeman, P. M., & Tallerico, T. (2003) · Synapse · doi:10.1002/syn.10171 · Cited by 20
Self-citationMele, A., Wozniak, K. M., Hall, F. S., & Pert, A. (1998) · Psychopharmacology · doi:10.1007/s002130050491 · Cited by 16
Phencyclidine-induced inhibition of rat prolactin secretion: Increased portal blood dopamine
Meltzer, H. Y., Simonovic, M., & Gudelsky, G. A. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90042-1 · Cited by 10
Comment on "Diverse Psychotomimetics Act Through a Common Signaling Pathway"
Seeman, P. M. (2004) · Science · doi:10.1126/science.1096072 · Cited by 6
Self-citationResponse to Comment on "Diverse Psychotomimetics Act Through a Common Signaling Pathway"
Svenningsson, P., Nomikos, G. G., & Greengard, P. (2004) · Science · doi:10.1126/science.1097564 · Cited by 6
Research works printed but not linked: 1
- Van Rossum JM . The significance of dopamine-receptor blockade for the action of neuroleptic drugs. In: Brill H, Cole J, Deniker P, Hippius H, Bradley PB (eds). Neuropsychopharmacology, Proceedings of the 5th Collegium Internationale Neuropsychopharmacologicum. Excerpta Medica Foundation: Amsterdam, 1967, pp 321–329.
Cited by
Belmaker, R. H., & Agam, G. (2008) · New England Journal of Medicine · doi:10.1056/nejmra073096 · Cited by 2,166
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
“0 mM) for D2 receptors (D2Rs; Kapur and Seeman, 2002; Seeman et al., 2005) and to act as a partial agonist at these receptors (EC50 = 0.”
BackgroundSchwenk, E. S., Viscusi, E. R., Buvanendran, A., Hurley, R. W., Wasan, A. D., Narouze, S., Bhatia, A., Davis, F. N., Hooten, W. M., & Cohen, S. P. (2018) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0000000000000806 · Cited by 584
A brief history of the development of antidepressant drugs: From monoamines to glutamate.
Hillhouse, T. M., & Porter, J. H. (2015) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0038550 · Cited by 605
Role of central dopamine in pain and analgesia
Wood, P. B. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.781 · Cited by 370
Metadata
- Authors
- Seeman, P., Ko, F., & Tallerico, T.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Seeman, P
- ORCID
- Seeman, P
- Venue
- Molecular Psychiatry
- Published
- 2005-04-26
- Volume
- 10
- Issue
- 9
- Pages
- 877-883
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2024217117
- Cited by
- 200
- References
- 38
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 8 · 2023: 4 · 2022: 4 · 2021: 8 · 2020: 10 · 2019: 8 · 2018: 11 · 2017: 9 · 2016: 5 · 2015: 14 · 2014: 5 · 2013: 9 · 2012: 9
- FWCI
- 8.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- dopamine D2 receptor, NMDA receptor, phencyclidine, ketamine, LSD, MK-801, psychotomimetics, schizophrenia, receptor binding affinity, dissociation constant
- MeSH terms
- Animals, Cloning, Molecular, Corpus Striatum, Domperidone, Dopamine, Cricetinae, Ketamine, Kinetics, Lysergic Acid Diethylamide, Membrane Glycoproteins, Nerve Tissue Proteins, Phencyclidine, Dizocilpine Maleate, CHO Cells, Receptors, Dopamine D2, Excitatory Amino Acid Antagonists, Membrane Transport Proteins, Dopamine Plasma Membrane Transport Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.